http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013202407-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9189a0ff62c994b3beb368015942b88a |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate | 2013-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f66278998ba62200d78815719bda01c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ccc39389740b57e88bc1039230c1f80 |
publicationDate | 2015-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2013202407-B2 |
titleOfInvention | Anti-TNF antibodies and methotrexate in the treatment of autoimmune disease |
abstract | Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation. |
priorityDate | 1996-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 223.